[1] DEVITA VT,HELLMAN S,ROSENBERG SA,Cancer,principles & practice of oncology[M].7th ed.2005,Philadelphia,PA:Lippincott Williams & Wilkins.lxxv,2898.
[2] MAHDAVIFAR N,GHONCHEH M,MOHAMMADIAN-HAFSHEJANI A,et al.Epidemiology and inequality in the Incidence and mortality of nasopharynx cancer in Asia[J].Osong Public Health Res Perspect,2016,7(6):360.
[3] CAO SM,SIMONS MJ,QIAN CN.The prevalence and prevention of nasopharyngeal carcinoma in China[J].Chin J Cancer,2011,30(2):114.
[4] WEI KR,ZHENG RS,ZHANG SW,et al.Nasopharyngeal carcinoma incidence and mortality in China[J].2013,Chin J Cancer,2017,36(1):90.
[5] BAR-SELA G,KUTEN A,MINKOV I,et al.Prevalence and relevance of EBV latency in nasopharyngeal carcinoma in Israel[J].Journal of Clinical Pathology,2004,57(3):290.
[6] TORRE LA,BRAY F,SIEGEL RL,et al.Global cancer statistics,2012[J].CA Cancer J Clin,2015,65(2):87.
[7] LI X,FASANO R,WANG E,et al.HLA associations with nasopharyngeal carcinoma[J].Curr Mol Med,2009,9(6):751.
[8] HILDESHEIM A,WANG CP.Genetic predisposition factors and nasopharyngeal carcinoma risk:A review of epidemiological association studies,2000-2011 Rosetta Stone for NPC:Genetics,viral infection,and other environmental factors[J].Semin Cancer Biol,2012,22(2):107.
[9] 汪庚明,江浩,张磊,等.肿瘤转移抑制基因KiSS-1在鼻咽癌中的表达及其意义.蚌埠医学院学报,2009,34(7):579.
[10] 徐洪波,汪庚明,江浩,等.KiSS-1基因在人鼻咽癌细胞株中的表达探讨.中华全科医学,2011,9(12),1833.
[11] RINGEL MD,HARDY E,BERNET VJ,et al.Metastin receptor is overexpressed in papillary thyroid cancer and activates MAP kinase in thyroid cancer cells[J].J Clin Endocrinol Metab,2002,87(5):2399.
[12] SULZMAIER FJ,JEAN C,SCHLAEPFER DD.FAK in cancer:mechanistic findings and clinical applications[J].Nat Rev Cancer,2014,14(9):598.
[13] ROSKOSKI R.ERK1/2 MAP kinases:structure,function,and regulation[J].Pharmacol Res,2012,66(2):10.
[14] ZHANG XD,HUANG G,XIE W,et al.The interaction of lncRNA EZR-AS1 with SMYD3 maintains overexpression of EZR in ESCC cells[J].Nucleic Acids Res,2018,46(4):1793.
[15] PENG S,FAN S,LI X,et al.The expression of ezrin in NPC and its interaction with NGX6,a novel candidate suppressor[J].Cancer Sci,2007,98(3):341.
[16] MARTIN TA,WATKINS G,JIANG WG.KiSS-1 expression in human breast cancer[J].Clin Exp Metastasis,2005,22(6):503.
[17] DHAR DK,NAORA H,KUBOTA H,et al.Downregulation of KiSS-1 expression is responsible for tumor invasion and worse prognosis in gastric carcinoma[J].Int J Cancer,2004,111(6):868.
[18] IKEGUCHI M,YAMAGUCHI K,KAIBARA N.Clinical significance of the loss of KiSS-1 and orphan G-protein-coupled receptor (hOT7T175) gene expression in esophageal squamous cell carcinoma[J].Clin Cancer Res,2004,10(4):1379.
[19] MASUI T,DOI R,MORI T,et al.Metastin and its variant forms suppress migration of pancreatic cancer cells[J].Biochem Biophys Res Commun,2004,315(1):85.
[20] JOHNSON TR,KHANDRIKA L,KUMAR B,et al.Focal adhesion kinase controls aggressive phenotype of androgen-independent prostate cancer[J].Mol Cancer Res,2008,6(10):1639.
[21] HILDESHEIM A,WANG CP.Genetic predisposition factors and nasopharyngeal carcinoma risk:A review of Epidemiological Association Studies,2000-2011[J].Semin Cancer Biol,2012,22(2):107.
[22] LIN DC,MENG X,HAZAWA M,et al.The genomic landscape of nasopharyngeal carcinoma[J].Nat Genet,2014,46(8):866.
[23] STRAZZULLA A,BARRECA GS,GIANCOTTI A,et al.Nasopharyngeal carcinoma:review of the literature with a focus on therapeutical implications[J].Infez Med,2015,23(3):224.
[24] SENTS W,MEEUSEN B,KALEV P,et al.PP2A inactivation mediated by PPP2R4 haploin sufficiency promotes cancer development[J].Cancer Res,2017,77(24):6825.
[25] TANG XR,LI Y,LIANG SB,et al.Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma:a retrospective,multicentre,cohort study[J].Lancet Oncol,2018,19(3):382.